K120299 is an FDA 510(k) clearance for the SRS ENDOSCOPIC STAPLING SYSTEM. Classified as Endoscopic Suture/plication System, Gastroesophageal Reflux Disease (gerd) (product code ODE), Class II - Special Controls.
Submitted by Medigus , Ltd. (Washington D.C., US). The FDA issued a Cleared decision on May 18, 2012 after a review of 108 days - within the typical 510(k) review window.
This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1500 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.
View all Medigus , Ltd. devices
NCT00734747
Completed
Interventional
Industry-sponsored
Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD)
Evaluation of the Medigus SRS Endoscopic Stapling System for the Treatment of Gastro-Esophageal Reflux Disease (GERD)
| Condition studied |
Gastroesophageal Reflux Disease (GERD) |
| Study design |
Single group |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Aviel Roy-Shapira, M.D. |
| Sponsor |
Aviel Roy-Shapira, M.D.
(industry)
|
Started 2008-05-01
→
Primary completion 2011-05-01
→
Completed 2015-07-01
Primary outcome
Percentage of Participants With >= 50% Improvement in GERD Health Related Quality of Life (GERD-HRQL - Velanovich) Score
Secondary outcome
Reduction of Acid Exposure (%Time pH<4) on Off PPI Ambulatory 24h Acid Exposure Test
View full study on ClinicalTrials.gov